Key Insights

Highlights

Treatment Research

2 treatments under study, led by Bevacizumab Dexamethasone Verteporfin Photodynamic Therapy

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01256580Not ApplicableWithdrawn

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Showing all 1 trials

Research Network

Common Treatments

  • Bevacizumab Dexamethasone Verteporfin Photodynamic Therapy1
  • Bevacizumab Avastin Genentech Inc1

Active Sponsors

  • Massachusetts Eye and Ear Infirmary1

Top Investigators

Related Conditions

  • Myopia1
  • Ocular Histoplasmosis Syndrome1
  • Trauma Or Hereditary Eye Diseases1
  • Multifocal Choroiditis1
  • Central Serous Chorioretinopathy Csc1

Activity Timeline